Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)

China · Delayed Price · Currency is CNY

53.39

-1.09 (-2.00%)

At close: Mar 9, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
In Vitro Diagnostic	4.53B	3.92B	3.05B	2.55B	2.19B
In Vitro Diagnostic Growth	15.50%	28.64%	19.70%	15.97%	30.53%
Unallocated Other Business	8.20M	9.91M	-	-	-
Unallocated Other Business Growth	-17.26%	-	-	-	-
Total	4.54B	3.93B	3.05B	2.55B	2.19B
Total Growth	15.41%	28.97%	19.70%	15.97%	30.53%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	2.85B	2.61B	2.08B	1.78B	1.37B
China Growth	9.24%	25.58%	16.73%	29.66%	2.48%
Foreign	1.69B	1.32B	970.13M	766.29M	822.82M
Foreign Growth	27.60%	36.23%	26.60%	-6.87%	140.16%
Total	4.54B	3.93B	3.05B	2.55B	2.19B
Total Growth	15.41%	28.97%	19.70%	15.97%	30.53%

Source: S&P Global Market Intelligence.